"Our experience in sub-Saharan Africa has taught us that fragile healthcare systems are among the root causes inhibiting expansion of treatment access for people living with HIV/AIDS and TB," said Gary Cohen, Executive Vice President, BD. "This unique public-private partnership between PEPFAR and BD enables us to apply our collaborative knowledge, expertise and resources toward strengthening health systems in the region, focused on improving laboratory testing capabilities."
This five-year public-private partnership, valued at up to $18 million, will focus on five primary areas:
-- Supporting country-specific programs working on the ground to develop
overarching integrated laboratory systems, services, and quality
-- Improving the quality of laboratory diagnostics critical to the
management of HIV/AIDS patients through training health personnel;
-- Implementing quality-control and quality-assurance guidelines and
supervisory tools for hematology, chemistry, CD4 testing and rapid HIV
-- Strengthening TB reference sites to serve as centralized training
-- Improving access to TB diagnostics for HIV-positive patients.
Accurate diagnosis is essential for successfully treating and preventing the spread of HIV/AIDS and other diseases. Laboratory settings in developing countries often lack resources and qualified health workers and have inadequate access to training for existing health workers. The partnership between BD and PEPFAR will support training and improved diagnostic capabilities critical to the management of HIV/AIDS patients.
The link between TB and HIV/AIDS is a significant global health
problem. In addition to improving laboratory
|SOURCE BD (Becton, Dickinson and Company)|
Copyright©2007 PR Newswire.
All rights reserved